Vis enkel innførsel

dc.contributor.authorSyversen, Silje Watterdal
dc.contributor.authorJyssum, Ingrid
dc.contributor.authorTveter, Anne Therese
dc.contributor.authorTran, Trung
dc.contributor.authorSexton, Joseph
dc.contributor.authorProvan, Sella Aarrestad
dc.contributor.authorMjaaland, Siri
dc.contributor.authorWarren, David
dc.contributor.authorKvien, Tore Kristian
dc.contributor.authorGrødeland, Gunnveig
dc.contributor.authorNissen-Meyer, Lise Sofie Haug
dc.contributor.authorRicanek, Petr
dc.contributor.authorChopra, Adity
dc.contributor.authorAndersson, Ane Marte
dc.contributor.authorKro, Grete Anette Birkeland
dc.contributor.authorJahnsen, Jørgen
dc.contributor.authorMunthe, Ludvig Andre
dc.contributor.authorHaavardsholm, Espen A.
dc.contributor.authorVaage, John T.
dc.contributor.authorLund-Johansen, Fridtjof
dc.contributor.authorJørgensen, Kristin Kaasen
dc.contributor.authorGoll, Guro Løvik
dc.date.accessioned2023-01-25T13:13:57Z
dc.date.available2023-01-25T13:13:57Z
dc.date.created2022-10-17T13:27:27Z
dc.date.issued2022
dc.identifier.citationArthritis & Rheumatology. 2022, 74 (8), 1321-1332.
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11250/3046328
dc.language.isoeng
dc.titleImmunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
dc.title.alternativeImmunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.description.versionpublishedVersion
dc.source.pagenumber1321-1332
dc.source.volume74
dc.source.journalArthritis & Rheumatology
dc.source.issue8
dc.identifier.doi10.1002/art.42153
dc.identifier.cristin2062018
dc.relation.projectNorges forskningsråd: 328657
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel